237 related articles for article (PubMed ID: 24195605)
21. Biosafety of gene therapy vectors derived from herpes simplex virus type 1.
Lim F; Khalique H; Ventosa M; Baldo A
Curr Gene Ther; 2013 Dec; 13(6):478-91. PubMed ID: 24397529
[TBL] [Abstract][Full Text] [Related]
22. Progress with retroviral gene vectors.
Palù G; Parolin C; Takeuchi Y; Pizzato M
Rev Med Virol; 2000; 10(3):185-202. PubMed ID: 10815029
[TBL] [Abstract][Full Text] [Related]
23. [Development and application of gene therapy technologies].
Ozawa K
Uirusu; 2004 Jun; 54(1):49-57. PubMed ID: 15449904
[TBL] [Abstract][Full Text] [Related]
24. A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration.
Loew R; Meyer Y; Kuehlcke K; Gama-Norton L; Wirth D; Hauser H; Stein S; Grez M; Thornhill S; Thrasher A; Baum C; Schambach A
Gene Ther; 2010 Feb; 17(2):272-80. PubMed ID: 19865181
[TBL] [Abstract][Full Text] [Related]
25. Genotoxicity of retroviral hematopoietic stem cell gene therapy.
Trobridge GD
Expert Opin Biol Ther; 2011 May; 11(5):581-93. PubMed ID: 21375467
[TBL] [Abstract][Full Text] [Related]
26. Biosafety in Handling Gene Transfer Vectors.
Swindle S
Curr Protoc Hum Genet; 2018 Jan; 96():12.1.1-12.1.17. PubMed ID: 29364521
[TBL] [Abstract][Full Text] [Related]
27. Retroviral Vectors for Cancer Gene Therapy.
Schambach A; Morgan M
Recent Results Cancer Res; 2016; 209():17-35. PubMed ID: 28101685
[TBL] [Abstract][Full Text] [Related]
28. Targeting of retroviral vectors for gene therapy.
Salmons B; Günzburg WH
Hum Gene Ther; 1993 Apr; 4(2):129-41. PubMed ID: 8494923
[TBL] [Abstract][Full Text] [Related]
29. Safety issues related to retroviral-mediated gene transfer in humans.
Cornetta K; Morgan RA; Anderson WF
Hum Gene Ther; 1991; 2(1):5-14. PubMed ID: 1863639
[TBL] [Abstract][Full Text] [Related]
30. Biosafety in handling gene transfer vectors.
Braun A
Curr Protoc Hum Genet; 2006 Aug; Chapter 12():Unit 12.1. PubMed ID: 18428388
[TBL] [Abstract][Full Text] [Related]
31. Pseudotyped Viruses for Retroviruses.
Solomon M; Liang C
Adv Exp Med Biol; 2023; 1407():61-84. PubMed ID: 36920692
[TBL] [Abstract][Full Text] [Related]
32. The retroviral vector family: something for everyone.
Elsner C; Bohne J
Virus Genes; 2017 Oct; 53(5):714-722. PubMed ID: 28762206
[TBL] [Abstract][Full Text] [Related]
33. Introduction to retroviruses and retroviral vectors.
Buchschacher GL
Somat Cell Mol Genet; 2001 Nov; 26(1-6):1-11. PubMed ID: 12465459
[TBL] [Abstract][Full Text] [Related]
34. Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo.
Bilbao G; Feng M; Rancourt C; Jackson WH; Curiel DT
FASEB J; 1997 Jul; 11(8):624-34. PubMed ID: 9240964
[TBL] [Abstract][Full Text] [Related]
35. Hepatic gene therapy: efficient retroviral-mediated gene transfer into rat hepatocytes in vivo.
Kolodka TM; Finegold M; Kay MA; Woo SL
Somat Cell Mol Genet; 1993 Sep; 19(5):491-7. PubMed ID: 7980740
[TBL] [Abstract][Full Text] [Related]
36. Vaccinia viral/retroviral chimeric vectors.
Falkner FG; Holzer GW
Curr Gene Ther; 2004 Dec; 4(4):417-26. PubMed ID: 15578991
[TBL] [Abstract][Full Text] [Related]
37. Retroviral approaches to gene therapy of cystic fibrosis.
Johnson LG
Ann N Y Acad Sci; 2001 Dec; 953():43-52. PubMed ID: 11795422
[TBL] [Abstract][Full Text] [Related]
38. Biosynthetic retrovectoring systems for gene therapy.
Hodgson CP; Xu G; Solaiman F; Zink MA
J Mol Med (Berl); 1997 Apr; 75(4):249-58. PubMed ID: 9151211
[TBL] [Abstract][Full Text] [Related]
39. Retroviral vectors for persistent expression in vivo.
Naviaux RK; Verma IM
Curr Opin Biotechnol; 1992 Oct; 3(5):540-7. PubMed ID: 1368938
[TBL] [Abstract][Full Text] [Related]
40. Retroviral vectors for gene therapy.
Maier P; von Kalle C; Laufs S
Future Microbiol; 2010 Oct; 5(10):1507-23. PubMed ID: 21073311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
